期刊文献+

地奈德水性凝胶的制备及透皮研究 被引量:2

Study on preparation and percutaneous penetration of Desonide aqueous gel
下载PDF
导出
摘要 目的研制地奈德水性凝胶,建立其质量控制方法并对其体外透皮吸收性能进行观察。方法以地奈德为主药制备凝胶,考察其稳定性并用高效液相色谱法(HPLC)法测定地奈德的含量。采用改进的Franz扩散池,以家兔离体皮肤为透皮模型,使用HPLC法测定药物在透皮接收液中的浓度及皮肤中药物滞留量。结果该制剂具有较好的稳定性,凝胶剂中地奈德的平均回收率为98.5%~101.3%。离体条件下,药物皮肤滞留量可达对照乳膏的1.87倍。结论所制备的地奈德凝胶能显著增加药物在皮肤中的滞留量,有望成为地奈德局部给药的新制剂。 ObjectiveTo develop the Desonide aqueous gel, and establish its quality control method, then observe the in vitro percutaneous absorption properties. MethodsThe gel was prepared, using Desonide as the main drug. The gel’s stability was observed, and the content of Desonide was detected by High performance liquid chromatography (HPLC). Using improved Franz diffusion cell, and isolated rabbit skin as transdermal model, HPLC was chose to detect the concentration of Desonide in percutaneous absorption liquid and Desonide retained in the skin. ResultsThe preparation has good stability, the average recovery rate of Desonide in the gel is 98.5%-101.3%. Under the condition of in vitro, the amount of drug retention were 1.87 times that of the control emulsifiable paste. ConclusionThe preparation of Desonide gel can significantly increase the retention of the drug in the skin, is expected to become the Desonide local to the new preparation.
出处 《微创医学》 2017年第2期183-186,共4页 Journal of Minimally Invasive Medicine
基金 广西壮族自治区卫生厅科研课题(编号:Z2014186)
关键词 地奈德 凝胶 质量控制 透皮 Desonide Gel Quality control Transdermal
  • 相关文献

参考文献3

二级参考文献16

  • 1Lucky AW,Grote GD,Williams JL,et al.Effect of desonide ointment,0.05%,on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.Cutis,1997,59:151-153.
  • 2Freeman S,Howard A,Foley P,et al.Efficacy,cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis.Australas J Dermatol,2002,43:186-189.
  • 3Frost P,Horwitz SN.Clinical comparison of alclometasone dipropionate and desonide ointments (0.05%) in the management of psoriasis.J Int Med Res,1982,10:375-378.
  • 4Jorizzo J,Levy M,Lucky A,et al.Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.J Am Acad Dermatol,1995,33:74-77.
  • 5罗明生.药剂辅料大全[M].成都:四川科学技术出版社.1999.
  • 6侯惠民.药用辅料应用技术[M].第2版.北京:中国医药科技出版社,2003.
  • 7平其能.现代药剂学[M].北京:中国医药卫生出版社,2000,1.212.
  • 8郑俊民.药用辅料手册[M].北京:化学工业出版社,2005
  • 9Lucky AW,Grote GD,Williams JL. Effect of desonide ointment,0.05%,on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis[J].Cutis:Cutaneous Medicine for the Practitioner,1997.151-153.
  • 10Freeman S,Howard A,Foley P. Efficacy,cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen)versus vehicle in the short-term treat ment of facial atopic or seborrhoeic dermatitis[J].Australasian Journal of Dermatology,2002.186-189.

共引文献95

同被引文献26

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部